Daniele Armenia is an associate professor of Microbiology and Clinical Microbiology at Saint Camillus International University of Health Sciences in Rome. Prof. Armenia is a biotechnologist and attended his PhD in Medical Microbiology and Immunology in 2010 at University of Rome “Tor Vergata”. He has been involved in studies on HIV-1 drug resistance since 2010 and he dedicated attention on the characterization, by both experimental and computational approaches, of structural and biological modifications of HIV integrase, reverse transcriptase and protease and also on HIV-1 tropism determination. His research activity pertains to the collection, management and analyses of data regarding genotypic resistance tests from HIV-1 infected patients, to characterize the mechanisms of development of resistance to protease, reverse transcriptase and integrase inhibitors. At this regard, he was involved in several studies evaluating reliability and the clinical relevance of genotypic resistance tests (GRTs) in a context of low-level viremia both from plasma and PBMC samples; moreover, he was involved in studies assessing the clinical relevance of HIV-1 resistance detected in plasma PBMCs both through next generation sequencing, in both viraemic and virologically suppressed individuals. Beyond HIV-1, he was also involved in bioinformatics and biostatistics management of next-generation sequencing data of HBV and HCV.
